USE OF BASAL INSULIN-GLP1 COMBINATION FOR THERAPEUTIC SIMPLIFICATION IN TYPE 2 DIABETIC PATIENTS WITH A BASAL-BOLUS OR BASAL PLUS SCHEME

被引:0
|
作者
Jaramillo-Nieto, A. [1 ]
Gomez Hernandez, I. [1 ]
Tique, C. [1 ]
机构
[1] Fdn Santa Fe Bogota, Endocrinol, Bogota, Colombia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
EP237 / #4
引用
收藏
页码:A180 / A180
页数:1
相关论文
共 50 条
  • [31] Insulin detemir and insulin aspart:: a promising basal-bolus regimen for type 2 diabetes
    Raslová, K
    Bogoev, M
    Raz, I
    Leth, G
    Gall, MA
    Hancu, N
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 66 (02) : 193 - 201
  • [32] ADAPTIVE BASAL-BOLUS ADVISOR FOR INSULIN TREATED PEOPLE WITH TYPE 2 DIABETES
    Panagiotou, M.
    Brigato, L.
    De Galan, B.
    Mougiakakou, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A90 - A91
  • [33] Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
    Moreira, Rodrigo Oliveira
    Cobas, Roberta
    Lopes Assis Coelho, Raquel C.
    DIABETOLOGY & METABOLIC SYNDROME, 2018, 10
  • [34] Combination of basal insulin and GLP-1 receptor agonist: is this the end of basal insulin alone in the treatment of type 2 diabetes?
    Rodrigo Oliveira Moreira
    Roberta Cobas
    Raquel C. Lopes Assis Coelho
    Diabetology & Metabolic Syndrome, 10
  • [35] Predictors of Hypoglycemic Events in Type 2 Diabetic Patients on Basal Insulin, Oral Antidiabetic Treatment and a Single Daily Bolus of Insulin Glulisine (Basal-Plus)
    Siegmund, Thorsten
    Brath, Helmut
    Bramlage, Peter
    Seufert, Jochen
    DIABETES, 2013, 62 : A590 - A591
  • [36] Efficacy and safety of 6-month treatment with insulin detemir in type 1 diabetic patients on a basal-bolus regimen
    Roberts, A
    Standl, E
    Bayer, T
    Munksgaard, E
    Lang, H
    DIABETOLOGIA, 2001, 44 : A207 - A207
  • [37] Efficacy and Durability of Exenatide in Combination with Pioglitazone vs. Basal-Bolus Insulin in Poorly Controlled Type 2 Diabetic Patients: The QATAR Study
    Abdul-Ghani, Muhammad
    Mujahed, Osama
    Mujahed, Ayman
    Hassoun, Shai-Maa
    Alkasem, Meis
    Abou Samra, Abdel Badi
    Zirie, Mahmoud
    Defronzo, Ralph A.
    Jayyousi, Amin
    DIABETES, 2016, 65 : A49 - A49
  • [38] Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
    Mehta, Roopa
    Billings, Liana K.
    Liebl, Andreas
    Vilsboll, Tina
    DIABETIC MEDICINE, 2022, 39 (09)
  • [39] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [40] USE OF INSULIN-BOLUS CALCULATOR FREE STYLE INSULINX® IN DIABETES TYPE-1 PATIENTS TREATED WITH BASAL-BOLUS INSULIN REGIMEN
    Delgado, E.
    Tejera, C.
    Bellido, D.
    Morales, F.
    Porca, C.
    Diaz Perez De Madrid, Jose
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A74 - A74